Does stenting with or without abciximab improve outcomes compared to angioplasty in acute myocardial infarction?
Stent implantation, with or without abciximab, is recommended as the routine reperfusion strategy for acute myocardial infarction at experienced centers.
At experienced centers, stent implantation (with or without abciximab therapy) should be considered the routine reperfusion strategy.
Stone et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: